1. Introduction {#sec1}
===============

The presence of a viable control is important for any research study, allowing for valid comparison to the condition of interest. Randomized controlled trials (RCTs) are the primary way that many areas of research examine the comparative effectiveness of verum and control conditions. Patient blinding in these studies is essential for gathering reliable results that can be expanded upon. However, blinding success in nonpharmacologic interventions, such as acupuncture, can be difficult to assess, and results may not be applicable from one study to the next, due to differences in control methods and in how blinding success is determined, if it is considered at all. The CONSORT 2010 Statement on blinding suggests that it is important to include how blinding was attempted, but there is no mention in the statement of how to assess whether blinding was successful \[[@B1]\]. Without knowing if the specific nonpharmacologic blinding techniques used are valid overall, the information collected may or may not be reliable. We believe it is imperative that blinding success be assessed toward better understanding of the reliability of results.

With respect to acupuncture research specifically, developing a control procedure that is physiologically inert and indistinguishable from true treatment has proven to be a challenge due to the very nature of traditional acupuncture. It has resulted in a variety of control methods that up until now have not been compared in terms of blinding success \[[@B57]--[@B9]\]. The traditional techniques of acupuncture (penetrating needles at acupoints for different organ systems and deqi) are the verum conditions of most acupuncture studies. Control conditions include penetrating needles at "nonpoints" and "wrong points," commercially-developed nonpenetrating devices, homemade nonpenetrating needles, and toothpicks or cocktail sticks \[[@B7]--[@B27]\]. "Nonpoints" are points not used for any purpose in traditional acupuncture. For the "wrong points," sham acupuncture is done at points thought to affect a different body system than the one targeted by the verum condition. However, the "wrong point" method may cause a physiological effect similar to that of acupuncture and, therefore, may be more appropriately considered to be verum than sham acupuncture \[[@B34]\].

To date, there is no standard or universally accepted sham procedure for acupuncture research and no quantitative comparison of blinding between the above sham methods. This may contribute to why there is a discrepancy between the clinically recognized effectiveness of acupuncture and the relative lack of research supporting it \[[@B35]\]. Methodological progress for blinding characteristics, including the amount of disclosure to study participants, the variables to be collected, the analytic design, and the interpretation strategy, is needed in validation studies of sham control procedures \[[@B37]\].

The present meta-analysis systematically examines the status of blinding in sham acupuncture RCTs via a numerical measure of blinding index. Our primary aim is to empirically evaluate the validity (via effectiveness of blinding) of sham control techniques in order to quantitatively assess blinding across available studies. We hope to determine the reliability of the results of studies that used different sham techniques, so that we may learn which sham methods are most useful for future acupuncture research. We also believe that our systematic review is just the beginning of increasing the validity of the assessment of quantitatively assessed blinding practices in acupuncture research. Our methods can be further extended as a model to assess other nonpharmacologic treatments\' blinding techniques.

2. Methods {#sec2}
==========

2.1. Data Sources and Searches {#sec2.1}
------------------------------

PubMed, Embase, and Web of Knowledge databases were searched for scientific articles using the keywords "acupuncture," "sham acupuncture," or "sham procedure." A revised search was also performed with Ovid Medline using the keywords "acupuncture," "sham acupuncture," or "placebo acupuncture." Eligible studies were those that were randomized controlled in humans and were published in English between 1985 and 2011. Our search was not limited by patient diagnosis or by the part of the body where acupuncture was administered.

2.2. Study Selection {#sec2.2}
--------------------

A study was considered eligible for initial screening if the authors stated that they evaluated blinding. One of the authors (Moroz, Freed, or Tiedemann) determined if the study reported data on effectiveness of blinding (EOB) by specifically asking participants if they thought the treatment used verum (V, real needle used or needle penetrated the skin) or sham (S) needling techniques, with or without an option to say they did not know (DK). If the blinding evaluation data was not included or was unclear, the authors were contacted twice by e-mail and/or telephone and asked for additional blinding evaluation data or clarification. Studies whose authors did not respond or responded but no longer had access to the original data were excluded. Studies that used a credibility questionnaire, asking patients to choose whether or not they had received treatment based on the principles of Chinese medicine or another type of acupuncture, were excluded as well. In these studies, the patients\' ability to distinguish between verum and sham needling was not directly addressed and the questionnaire could be misinterpreted. If EOB was measured multiple times within the same study, the data collected at the end of the study or the data collected from the insertion (as opposed to sensation of deqi or needle withdrawal) arm of the study would be used. In one work that reported results of two separate studies using different acupuncture points, one on the patients\' back and the other on the upper extremity, the blinding index calculations were done independently \[[@B55]\].

2.3. Data Extraction {#sec2.3}
--------------------

For the studies that were included in this meta-analysis, the number of patients who responded as V, S, or DK was extracted from each trial. Additionally, the following variables were extracted from each of the included studies (we hypothesized a priori that these may be associated with EOB): year of publication, subject only or staff and subject blinding, time of blinding assessment, assessment of deqi, type of sham control device used, use of penetrating or nonpenetrating sham control, patient diagnosis, and number of days without acupuncture experience prior to participation. Research staff members that were blinded were those involved in data analysis and interpretation, not those administering acupuncture.

2.4. Data Synthesis and Analysis {#sec2.4}
--------------------------------

Statistical analyses were carried out using the blinding index (BI) in order to objectively assess EOB \[[@B6], [@B5]\]. Blinding index estimates the degree of potential unblinding beyond chance for each arm in a given study by counting the excessive numbers of correct guesses. Blinding index values are always between −1 and 1, where 1 corresponds to all correct guesses, whereas −1 corresponds to all incorrect or opposite guesses. If 50% of patient responses are correct and 50% are incorrect, then BI = 0; this is indicative of random guessing and thus is an ideal blinding scenario. Another plausible scenario indicating effective blinding is that patients tend to believe they received active treatment regardless of actual treatment received, which may reflect patients\' wish to receive active intervention. In this case, blinding index will have a positive value in the active treatment arm and a negative value in the sham treatment arm, where this scenario is denoted later as unblinded/opposite.

Verum and sham acupuncture groups were each assigned a separate blinding index value. Based on the calculated blinding index value combinations for the two treatment arms, nine possible blinding scenarios were proposed ([Table 1](#tab1){ref-type="table"}). For classification purposes, we decided to consider BI ≥ 0.2 unblinded; −0.2 \< BI \< 0.2 random guesses; BI ≤ −0.2 opposite guesses \[[@B38], [@B5], [@B28]\]. (Remark: this cutoff value was based on authors\' consensus and used as a general tool for classification and explanation; it should not be interpreted as an absolute indication of blinding effectiveness.)

Individual variables hypothesized to potentially impact EOB were compared by their average VBI and SBI scores, weighted by sample size. The weighted averages were used to determine the overall blinding index scenario for each variable. Blinding scenarios were also compared to the overall outcome of each study. Finally, we looked for patterns of possible association of study design factors with EOB based on blinding index values and scenarios. The factors included were based on data extraction criteria, sample size, timing of blinding assessment, blinded parties, sensation assessed, subject\'s status, subject\'s experience, and sham device used.

3. Results {#sec3}
==========

3.1. Data Search {#sec3.1}
----------------

Using our search inclusion criteria, 590 peer reviewed journal articles were found, with 186 of these reporting blinding data in RCTs. 133 studies were excluded from the review, most often due to a lack of patient guess of treatment allocation. One article reported two distinct studies that were included separately \[[@B55]\]. Fifty-four studies were included in our final analysis, with a total of 4783 patients ([Figure 1](#fig1){ref-type="fig"}).

3.2. Blinding Index Calculations {#sec3.2}
--------------------------------

The blinding index values (point and interval estimates) computed from all 54 studies can be found in [Figure 2](#fig2){ref-type="fig"}. The average weighted blinding index values for the entire review were 0.34 for verum and −0.20 for sham groups, respectively. Overall, a correct guess is quite common in the verum arm, and opposite guess is not uncommon in the sham arm.

After grouping studies into the nine possible blinding scenarios based on the blinding index ([Table 1](#tab1){ref-type="table"}), 33 out of 54 (61%) of the studies might be adequately blinded. Of these, 70% (23/33) had a positive outcome reported overall; similarly, 62% (13/21) with less ideal blinding had an overall positive outcome ([Table 3](#tab3){ref-type="table"}). Unblinded/opposite for V, S is most common, with 46% of the studies belonging to this scenario, followed by unblinded/random with 22%.

3.3. Design Characteristics and Effectiveness of Blinding {#sec3.3}
---------------------------------------------------------

The variables hypothesized to affect blinding were compared by their average VBI and SBI values, and blinding scenarios in [Table 2](#tab2){ref-type="table"}.

Of the 54 studies, 22 studies used a commercially developed sham control device, 14 studies used a custom-made sham control device, 12 used penetrating sham control, and 6 used a toothpick or cocktail stick. According to their averaged blinding index scenarios, all of the sham control devices with the exception of custom devices seemed to be effective in blinding the subjects, with the penetrating sham controls providing relatively more effective blinding.

In looking at the penetrating versus nonpenetrating dichotomy in a more direct way, the nonpenetrating group was unblinded/opposite, the mixed penetrating/nonpenetrating group was unblinded/opposite, and the penetrating group was random/random. All of these scenarios indicated effective blinding.

Studies with a greater number of subjects had a greater unblinding in the verum group. Measurements assessed later tended to have more ideal effectiveness of blinding than measurements assessed immediately. Interestingly, there was a higher tendency in both arms, when only the subjects---not staff---were blinded, to believe they received the verum treatment. The deqi group had slightly better EOB than the insertion/puncture group, and the symptomatic group had more ideal EOB than the healthy group.

Twenty-four studies used acupuncture-naïve subjects, and 19 used subjects with prior acupuncture experience. Eleven of the studies were excluded from this section of the review due to unknown prior experience or mixed experience of the subjects. According to their averaged blinding index scenarios, both groups were unblinded/random.

4. Discussion {#sec4}
=============

This systematic review of 54 randomized controlled acupuncture studies showed that overall 61% of the studies (as a conservative estimate) meeting our inclusion/exclusion criteria were effectively blinded. The most common scenario encountered was unblinded in the acupuncture group and opposite guess in the sham acupuncture group, which could be indeed interpreted as "well-blinded." In this scenario there may be a psychological phenomenon of "wishful thinking." A majority of people, in both the verum and sham groups, guessed that they received real acupuncture. Thus, guesses are inflated towards real acupuncture in both study arms. It is also possible that once a needle is administered, a subject believes it is real acupuncture, or subjects may not know what to expect, creating a similar trend, or there is a strong placebo effect.

A similar pattern emerges when looking at the V and S groups individually; the average VBI was "unblinded" and the average SBI was "opposite." Is it possible for one not to know when a needle is penetrating his or her skin? Perhaps the answer is "no," given that unblinded V may mean that subjects know when their skin is being penetrated by a needle and thus increases the chance a subject chooses the V acupuncture group over the S acupuncture group upon questioning. Is it possible for one to know when a needle is not penetrating their skin? The answer seems to be "no" again; opposite guesses in S may indicate that subjects are not able to tell if they are not being penetrated by a needle, and thus are truly guessing.

Most sham control devices with the exception of custom devices were effective in blinding the subjects ([Table 2](#tab2){ref-type="table"}). Since there was a great diversity within the custom sham group a more in depth case by case analysis of each device could be performed, but at this time there does not seem to be compelling evidence supporting the use of custom sham devices. Even though commercial sham devices and toothpick/cocktail stick devices appear to provide effective blinding, the penetrating sham controls provided relatively more effective blinding.

By comparing study blinding and study outcomes, the majority of studies reported positive outcomes, regardless of the degree of guess correctness. This leads us to believe that there is no obvious association between EOB and reported study outcomes. The current literature provides conflicting evidence so the direction of bias may be specific to context or treatment \[[@B7]--[@B27], [@B4]--[@B22], [@B33]--[@B60]\] or random.

Exploration of individual variables and their possible effect on EOB indicated that some design characteristics such as larger sample size, symptomatic subjects, and later assessment were associated with more effective blinding, and these may be encouraged to be further evaluated and considered in designing future acupuncture trials.

4.1. Recommendations for Future Acupuncture Research {#sec4.1}
----------------------------------------------------

The effect size was not a part of the extracted information from the reviewed studies. This poses an interesting idea for future investigation. Additional future research should include a sufficiently powered, prospective randomized trial comparing the EOB of different methods and sham devices by direct comparison, as well as investigating the influence of practitioner behavior, the patient\'s expectations and beliefs, and the location of treatment points on blinding effectiveness. A good treatment should have a greater treatment effect than placebo effect. It is important that we collect more data in this field, especially qualitative data (e.g., reasons of guessing in a particular way). It is possible that the reasons for correct guesses in individual trials may be more revealing than our numbers. Individual trialists should be willing to share their experiences with others, as individual trialists and patients must have greater insight and more stories to tell in specific conditions within the trial than meta-analysis and readers. This is particularly important, because any analysis of available numeric data on blinding is destined to be prone to some biases.

4.2. Systematic Review Limitations {#sec4.2}
----------------------------------

There are several potential weaknesses of this review that we recognize. Language bias may be a possibility given that we included only English language publications while acupuncture is a popular treatment modality in Asia and Europe. There is also a possibility of publication bias, which is an inherent problem in virtually all systematic reviews or meta-analyses. Moreover, it is possible that some investigators collected blinding data, saw the data, and decided not to report it in the paper, particularly when blinding was shown to be unsatisfactory. Also, for classification and decision making purposes, we used categorization/dichotomization (e.g., numerical BI cutoff of 0.2) and summary statistics (e.g., average BI). Alternative ways of analyzing the data could yield different results. Finally, in this systematic review, we used the conventional terms commonly used in the literature and equated "unblinded" with "correctly guessed," whereas there could be other reasons for correct guesses. With its limitations, to our knowledge, this is the first systematic review based on empirical blinding data.

In conclusion, based on the status of blinding, the most common scenario encountered was a more correct guess in the real acupuncture group and an opposite guess in the sham acupuncture group, and the overall subject blinding of the evaluated acupuncture studies was satisfactory. In addition, quantitatively calculated blinding data, ideally together with more qualitative data for individual trials, may offer meaningful means to further interpret the findings of RCTs and improve the practice in the direction of a higher validity.

J. J. Park developed the Park Sham Device via AcuPrime in UK and was supported by the National Institute of Dental and Craniofacial Research of the National Institute of Health under award number K12DE022793. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.

The authors acknowledge the assistance of Hannah McFadden during the preparation of the paper.

![Systematic review search and selection. \*One article contained two separate studies.](ECAM2013-708251.001){#fig1}

![(a) Verum and (b) sham. Blinding index values with 95% confidence intervals. \*Individual blinding index estimate and confidence intervals raw data are provided in [Table 3](#tab3){ref-type="table"}. Confidence intervals are unadjusted for multiple comparisons.](ECAM2013-708251.002){#fig2}

###### 

Blinding scenarios \[[@B38]\].

  Experimental arm (verum)   Control arm (sham)   Possible blinding and clinical effectiveness interpretations                                                                                                                Trials number (%)
  -------------------------- -------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------
  Random guess               Random guess         Ideal, possibly most ideal from the scientific or statistical perspective                                                                                                   8 (15)
  Random guess               Opposite guess       Rare                                                                                                                                                                        2 (4)
  Random guess               Unblinded            Possibly little treatment effect and completely no effect in control arm                                                                                                    3 (6)
  Unblinded                  Unblinded            Possibly problematic. Treatment effect in experimental arm and no treatment effect in control arm (e.g., patients tend to know what to expect)                              4 (7)
  Unblinded                  Opposite guess       Ideal (e.g., patients tend to have wishful thinking, strong placebo effect, and any treatment administered is perceived as real treatment)                                  25 (46)
  Unblinded                  Random guess         Possibly problematic. Treatment effect in experimental arm and no treatment effect in control arm (e.g., patients do not know what to expect in the absence of treatment)   12 (22)
  Opposite guess             Opposite guess       Rare                                                                                                                                                                        0 (0)
  Opposite guess             Random guess         Rare                                                                                                                                                                        0 (0)
  Opposite guess             Unblinded            No treatment effect at all; patients may have low expectations                                                                                                              0 (0)

###### 

Design characteristics that may be associated with blinding, compared by BI values and scenarios.

  ----------------------------------------------------------------------------------------------------------------
  Study characteristics               Number of studies   BI (V)   BI (S)   BI\               Blinding scenario
                                                                            (\|V\| − \|S\|)   
  ----------------------------------- ------------------- -------- -------- ----------------- --------------------
  Sample size                                                                                  

    *N* \< 100                        43                  0.44     −0.19    0.25              Unblinded/random

    *N* ≥ 100                         11                  0.28     −0.20    0.08              Unblinded/opposite

  Blinding assessed                                                                            

   Immediately                        19                  0.50     −0.19    0.31              Unblinded/random

   Later                              35                  0.29     −0.20    0.09              Unblinded/opposite

  Blinded parties                                                                              

   Subjects                           22                  0.52     −0.27    0.25              Unblinded/opposite

   Subjects + research staff          32                  0.26     −0.17    0.09              Unblinded/random

  Assessed for sensation of                                                                    

   Deqi                               22                  0.33     −0.21    0.12              Unblinded/opposite

   Puncture                           32                  0.35     −0.19    0.16              Unblinded/random

  Subject\'s status                                                                            

   Healthy                            12                  0.43     −0.06    0.37              Unblinded/random

   Symptomatic                        42                  0.33     −0.22    0.11              Unblinded/opposite

  Subject\'s acupuncture experience                                                            

   Naïve                              24                  0.27     −0.13    0.14              Unblinded/random

   Experienced                        19                  0.32     −0.19    0.13              Unblinded/random

  Sham device used                                                                             

   Commercial                         22                  0.47     −0.32    0.15              Unblinded/opposite

   Custom                             14                  0.48     −0.17    0.31              Unblinded/random

   Penetrating                        12                  0.16     −0.08    0.08              random/random

   Toothpick or cocktail stick        6                   0.55     −0.33    0.22              Unblinded/opposite
  ----------------------------------------------------------------------------------------------------------------

 \*Raw data available in [Table 4](#tab4){ref-type="table"}.

###### 

Blinding index values computed from 54 studies.

  Study                                        *N*   VBI     VBI 95% CI      SBI     SBI 95% CI       Scenario              Study outcome
  -------------------------------------------- ----- ------- --------------- ------- ---------------- --------------------- ---------------
  Assefi et al. 2005 \[[@B4]\]                 75    −0.17   −0.49 to 0.15   0.3     0.10 to 0.49     Random/unblinded      Negative
  Kaptchuk et al. 2008 \[[@B26]\]              148   0.12    −0.07 to 0.31   −0.52   −0.69 to −0.35   Random/opposite       Positive
  Kennedy et al. 2008 \[[@B27]\]               45    0.18    −0.13 to 0.49   −0.38   −0.70 to −0.05   Random/opposite       Positive
  Barlas et al. 2006 \[[@B7]\]                 48    −0.09   NA              −0.06   NA               Random/random         Positive
  Deng et al. 2008 \[[@B12]\]                  53    0.08    −0.30 to 0.46   0.19    −0.18 to 0.55    Random/random         Negative
  Enblom et al. 2008 \[[@B15]\]                80    0.2     0.00 to 0.40    0.1     −0.13 to 0.33    Random/random         Positive
  Endres et al. 2007 \[[@B16]\]                403   −0.16   −0.35 to 0.03   −0.04   −0.24 to 0.16    Random/random         Positive
  Haake et al. 2007 \[[@B20]\]                 692   −0.01   −0.09 to 0.07   0.11    0.03 to 0.19     Random/random         Positive
  Harris et al. 2009 \[[@B21]\]                20    0.2     −0.26 to 0.66   −0.2    −0.57 to 0.17    Random/random         Positive
  Shin et al. 2010 \[[@B44]\]                  42    −0.05   −0.35 to 0.18   0.05    −0.23 to 0.33    Random/random         Negative
  Zaslawski et al. 1997 \[[@B65]\]             64    0.12    −0.37 to 0.13   0.03    −0.28 to 0.21    Random/random         Positive
  Deng et al. 2007 \[[@B13]\]                  67    0       −0.29 to 0.29   0.46    0.17 to 0.75     Random/unblinded      Negative
  Jubb et al. 2008 \[[@B25]\]                  51    0.18    −0.14 to 0.51   0.3     0.03 to 0.56     Random/unblinded      Positive
  Alecrim-Andrade et al. 2006 \[[@B3]\]        24    0.21    0.11 to 0.33    −0.29   −0.37 to −0.20   Unblinded/opposite    Negative
  Berman et al. 2004 \[[@B8]\]                 283   0.73    0.63 to 0.82    −0.48   −0.61 to −0.35   Unblinded/opposite    Positive
  Brinkhaus et al. 2006 \[[@B10]\]             205   0.44    0.30 to 0.57    −0.24   −0.42 to −0.05   Unblinded/opposite    Positive
  Enblom et al. 2011 \[[@B14]\]                190   0.72    0.60 to 0.83    −0.6    −0.74 to −0.46   Unblinded/opposite    Positive
  Fink et al. 2001 \[[@B17]\]                  64    1       NA              −0.75   −0.98 to −0.52   Unblinded/opposite    Positive
  Goddard et al. 2005 \[[@B18]\]               49    0.58    0.26 to 0.91    −0.76   −1.01 to −0.50   Unblinded/opposite    Positive
  Goldman et al. 2008 \[[@B19]\]               118   0.42    0.24 to 0.60    −0.62   −0.77 to −0.47   Unblinded/opposite    Negative
  Itoh et al. 2006 \[[@B24]\]                  19    0.48    0.14 to 0.81    −0.32   −0.70 to 0.07    Unblinded/opposite    Positive
  Itoh et al. 2008 \[[@B23]\]                  24    0.56    0.01 to 1.10    −0.5    −1.10 to 0.10    Unblinded/opposite    Positive
  Lee et al. 2008 \[[@B31]\]                   89    0.91    0.79 to 1.03    −0.68   −0.90 to −0.47   Unblinded/opposite    Positive
  Lee et al. 2011 \[[@B32]\]                   35    0.23    −0.06 to 0.51   −0.56   −0.80 to −0.31   Unblinded/opposite    Positive
  Park et al. 2002 \[[@B40]\]                  58    0.38    0.20 to 0.56    −0.31   −0.48 to −0.14   Unblinded/opposite    Positive
  Park et al. 2005 \[[@B39]\]                  94    0.47    0.32 to 0.61    −0.31   −0.48 to −0.13   Unblinded/opposite    Negative
  Shen et al. 2009 \[[@B42]\]                  12    0.63    0.24 to 1.01    −0.5    −0.99 to −0.01   Unblinded/opposite    Positive
  Sherman et al. 2002 \[[@B43]\]               52    0.65    0.34 to 0.96    −0.52   −0.80 to −0.24   Unblinded/opposite    Positive
  Smith et al. 2007 \[[@B45]\]                 27    1       NA              −1      NA               Unblinded/opposite    Positive
  So et al. 2009 \[[@B46]\]                    370   0.52    0.43 to 0.61    −0.36   −0.46 to −0.25   Unblinded/opposite    Negative
  Streitberger and Kleinhenz 1998 \[[@B47]\]   60    0.8     0.65 to 0.95    −0.57   −0.77 to −0.36   Unblinded/opposite    Positive
  Streitberger et al. 2004 \[[@B48]\]          212   0.22    0.06 to 0.37    −0.25   −0.38 to −0.11   Unblinded/opposite    Negative
  Tong et al. 2010 \[[@B53]\]                  63    1       NA              −0.81   −1.06 to −0.56   Unblinded/opposite    Positive
  Tough et al. 2009 \[[@B54]\]                 37    0.57    0.30 to 0.75    −0.67   −0.93 to −0.40   Unblinded/opposite    Positive
  Venzke et al. 2010 \[[@B56]\]                51    0.48    0.15 to 0.81    −0.42   −0.78 to −0.05   Unblinded/opposite    Negative
  White et al. 1996 \[[@B61]\]                 9     1       NA              −0.6    −1.30 to 0.10    Unblinded/opposite    Negative
  White et al. 2000 \[[@B62]\]                 44    0.61    0.35 to 0.87    −0.26   −0.56 to 0.04    Unblinded/opposite    Negative
  White et al. 2007 \[[@B63]\]                 37    0.77    0.55 to 0.98    −0.29   −0.61 to 0.03    Unblinded/opposite    Positive
  Alecrim-Andrade et al. 2008 \[[@B2]\]        36    0.26    0.14 to 0.39    −0.12   −0.23 to −0.00   Unblinded/random      Negative
  Harris et al. 2005 \[[@B22]\]                76    0.25    −0.09 to 0.59   −0.13   −0.50 to 0.23    Unblinded/random      Negative
  Lao et al. 1999 \[[@B30]\]                   39    0.47    0.17 to 0.78    0.05    −0.21 to 0.31    Unblinded/random      Positive
  Linde et al. 2005 \[[@B33]\]                 201   0.5     0.38 to 0.63    −0.06   −0.26 to 0.15    Unblinded/random      Negative
  Nabeta and Kawakita 2002 \[[@B36]\]          34    0.41    0.01 to 0.81    −0.18   −0.61 to 0.26    Unblinded/random      Positive
  Shen and Goddard 2007 \[[@B41]\]             15    0.78    0.37 to 1.19    0       −0.80 to 0.80    Unblinded/random      Positive
  Streitberger et al. 2008 \[[@B49]\]          20    0.55    0.29 to 0.81    −0.15   0.46 to 0.16     Unblinded/random      Positive
  Takakura and Yajima 2007 \[[@B50]\]          60    0.6     0.40 to 0.80    0.17    −0.08 to 0.42    Unblinded/random      Positive
  Takakura and Yajima 2008 \[[@B51]\]          114   0.37    0.20 to 0.54    −0.12   −0.30 to 0.06    Unblinded/random      Positive
  Tan et al. 2009 \[[@B52]\]                   20    0.25    0.04 to 0.46    0.1     −0.12 to 0.32    Unblinded/random      Positive
  Tsukayama et al. 2006 BL23 \[[@B55]\]        20    0.4     −0.00 to 0.80   0       −0.44 to 0.44    Unblinded/random      Negative
  Wasan et al. 2010 \[[@B59]\]                 40    0.8     0.61 to 0.99    0       −0.31 to 0.31    Unblinded/random      Negative
  Chae et al. 2011 \[[@B11]\]                  28    0.57    0.14 to 1.00    0.71    0.35 to 1.08     Unblinded/unblinded   Positive
  Kreiner et al. 2010 \[[@B29]\]               32    0.34    0.11 to 0.57    0.44    0.22 to 0.66     Unblinded/unblinded   Positive
  Tsukayama et al. 2006 L14 \[[@B55]\]         20    1       NA              0.3     −0.12 to 0.72    Unblinded/unblinded   Negative
  Wayne et al. 2008 \[[@B60]\]                 14    0.22    −0.19 to 0.63   0.4     −0.30 to 1.10    Unblinded/unblinded   Positive

###### 

Study characteristics extracted from 54 studies.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                        Total *N*   Party blinded     Time of blinding assessment (days from beginning of study)   Deqi assessment (yES/nO)   Sham device   Penetration of sham   Study participant diagnosis             Days since last acupuncture experience
  -------------------------------------------- ----------- ----------------- ------------------------------------------------------------ -------------------------- ------------- --------------------- --------------------------------------- ----------------------------------------
  Shen and Goddard 2007 \[[@B41]\]             15          Staff + subject   0                                                            NO                         C             NP                    Chronic TM pain                         Unknown

  Itoh et al. 2006 \[[@B24]\]                  19          Staff + subject   21                                                           NO                         C             NP                    Chronic LBP                             Unknown

  Nabeta and Kawakita\                         34          Subject           28                                                           NO                         C             NP                    Chronic neck and shoulder pain          Unknown
  2002 \[[@B36]\]                                                                                                                                                                                                                                

  Tough et al. 2009 \[[@B54]\]                 37          Subject           14                                                           NO                         C             NP                    Whiplash                                Unknown

  Fink et al. 2001 \[[@B17]\]                  64          Staff + subject   14                                                           NO                         C             NP                    Tension headache                        Unknown

  Shen et al. 2009 \[[@B42]\]                  12          Staff + subject   0                                                            YES                        C             NP                    Chronic myofacial pain of jaw muscles   \>365

  Kreiner et al. 2010 \[[@B29]\]               32          Staff + subject   0                                                            NO                         C             NP                    Normal                                  \>365

  Lao et al. 1999 \[[@B30]\]                   39          Staff + subject   0.2                                                          YES                        C             NP                    After oral surgery Pain                 \>365

  Goddard et al. 2005 \[[@B18]\]               49          Subject           0                                                            YES                        C             NP                    Normal                                  \>365

  Jubb et al. 2008 \[[@B25]\]                  51          Subject           63                                                           YES                        C             NP                    Knee OA                                 \>365

  Itoh et al. 2008 \[[@B23]\]                  24          Staff + subject   35                                                           NO                         C             NP                    Knee OA                                 180

  Deng et al. 2008 \[[@B12]\]                  53          Subject           30                                                           NO                         C             NP                    After thoracotomy Pain                  42

  Takakura and Yajima\                         60          Staff + subject   0                                                            NO                         C             NP                    Normal                                  0
  2007 \[[@B50]\]                                                                                                                                                                                                                                

  Takakura and Yajima\                         114         Staff + subject   0                                                            YES                        C             NP                    Normal                                  0
  2008 \[[@B51]\]                                                                                                                                                                                                                                

  Smith et al. 2007 \[[@B45]\]                 27          Staff + subject   28                                                           NO                         P             NP                    TMJ                                     Unknown

  Tan et al. 2009 \[[@B52]\]                   20          Subject           0                                                            NO                         P             NP                    Normal                                  \>365

  Kennedy et al. 2008 \[[@B27]\]               45          Subject           42                                                           NO                         P             NP                    Acute LBP                               \>365

  Park et al. 2002 \[[@B40]\]                  58          Staff + subject   84                                                           NO                         P             NP                    Acute stroke                            \>365

  Park et al. 2005 \[[@B39]\]                  94          Staff + subject   14                                                           NO                         P             NP                    Stroke                                  \>365

  Enblom et al. 2011 \[[@B14]\]                190         Staff + subject   35                                                           NO                         P             NP                    Radiation-induced nausea                365

  Tsukayama et al. 2006\                       20          Staff + subject   0                                                            NO                         P             NP                    Normal                                  0
  BL23 \[[@B55]\]                                                                                                                                                                                                                                

  Tsukayama et al. 2006\                       20          Staff + subject   0                                                            NO                         P             NP                    Normal                                  0
  L14 \[[@B55]\]                                                                                                                                                                                                                                 

  Chae et al. 2011 \[[@B11]\]                  28          Subject           0                                                            NO                         P             NP                    Normal                                  0

  Shin et al. 2010 \[[@B44]\]                  42          Staff + subject   21                                                           YES                        PEN           P                     Dry eye                                 Unknown

  Tong et al. 2010 \[[@B53]\]                  63          Subject           15                                                           YES                        PEN           P                     DPN                                     \~50%

  Zaslawski et al. 1997 \[[@B65]\]             64          Subject           28                                                           YES                        PEN           P                     Stress                                  \~50%

  Harris et al. 2005 \[[@B22]\]                76          Staff + subject   21                                                           NO                         PEN           P                     Fibromyaligia                           \>365

  Haake et al. 2007 \[[@B20]\]                 692         Staff + subject   168                                                          NO                         PEN           P                     Chronic LBP                             \>365

  Linde et al. 2005 \[[@B33]\]                 201         Staff + subject   168                                                          YES                        PEN           P                     Migraine HA                             365

  Brinkhaus et al. 2006 \[[@B10]\]             205         Subject           56                                                           YES                        PEN           P                     Chronic LBP                             365

  Endres et al. 2007 \[[@B16]\]                403         Staff + subject   180                                                          YES                        PEN           P                     Tension headache                        365

  Alecrim-Andrade et al. 2006 \[[@B3]\]        24          Staff + subject   84                                                           YES                        PEN           P                     Migraine HA                             84

  Alecrim-Andrade et al. 2008 \[[@B2]\]        36          Subject           84                                                           YES                        PEN           P                     Migraine HA                             84

  Lee et al. 2011 \[[@B32]\]                   35          Staff + subject   70                                                           NO                         PEN           P                     Chronic pelvic pain                     42

  Lee et al. 2008 \[[@B31]\]                   89          Subject           70                                                           NO                         PEN           P                     Chronic prostatitis                     42

  White et al. 2007 \[[@B63]\]                 37          Subject           0                                                            YES                        S             NP                    Chronic Pain/Normal                     Unknown

  So et al. 2009 \[[@B46]\]                    370         Staff + subject   0                                                            NO                         S             NP                    Infertility                             Unknown

  Wayne et al. 2008 \[[@B60]\]                 14          Staff + subject   28                                                           NO                         S             NP                    Endometriosis                           \>365

  Streitberger et al. 2008 \[[@B49]\]          20          Subject           0                                                            NO                         S             NP                    Normal                                  \>365

  Wasan et al. 2010 \[[@B59]\]                 40          Subject           0                                                            YES                        S             NP                    Chronic LBP                             \>365

  Barlas et al. 2006 \[[@B7]\]                 48          Staff + subject   0                                                            YES                        S             NP                    Normal                                  \>365

  Streitberger and Kleinhenz 1998 \[[@B47]\]   60          Subject           0                                                            NO                         S             NP                    Normal                                  \>365

  Enblom et al. 2008 \[[@B15]\]                80          Subject           0                                                            NO                         S             NP                    Normal                                  \>365

  Kaptchuk et al. 2008 \[[@B26]\]              148         Staff + subject   42                                                           NO                         S             NP                    IBS                                     \>365

  Goldman et al. 2008 \[[@B19]\]               118         Staff + subject   28                                                           YES                        S             NP                    Arm pain                                365

  Venzke et al. 2010 \[[@B56]\]                51          Subject           168                                                          YES                        S             NP                    Hot flashes                             180

  Streitberger et al. 2004 \[[@B48]\]          212         Staff + subject   1                                                            YES                        S             NP                    postoperative nausea                    180

  Deng et al. 2007 \[[@B13]\]                  67          Subject           42                                                           YES                        S             NP                    Hot flashes                             42

  White et al. 1996 \[[@B61]\]                 9           Staff + subject   42                                                           NO                         T             NP                    Tension headache                        \>365

  Harris et al. 2009 \[[@B21]\]                20          Staff + subject   0                                                            NO                         T             NP                    Fibromyalgia                            \>365

  White et al. 2000 \[[@B62]\]                 44          Staff + subject   7                                                            YES                        T             NP                    Tension headache                        \>365

  Sherman et al. 2002 \[[@B43]\]               52          Subject           0                                                            NO                         T             NP                    Chronic LBP                             \>365

  Assefi et al. 2005 \[[@B4]\]                 75          Staff + subject   84                                                           NO                         T             NP, P                 Fibromyalgia                            \>365

  Berman et al. 2004 \[[@B8]\]                 283         Subject           182                                                          YES                        T             NP, P                 Knee OA                                 \>365
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Sham devices: C: custom sham, P: park sham, PEN: penetrating sham, S: streitberger sham, and T: toothpick.

[^1]: Academic Editor: Gerhard Litscher
